Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab neoadjuvant cycles in dMMR/MSI-H colorectal cancer
NCT06698757Phase 2Recruiting
- Start
- Nov 2024
- Primary completion
- Nov 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in colorectal cancer (CRC). Started Nov 2024; status: recruiting.
02
Drugs
sintilimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06698757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06698757.